Olivier Bezençon

Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies

Olivier Bezençon, Bibia Heidmann, Romain Siegrist et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

Generalized Epilepsies, Pharmaceutical Science, Compound 66B +18

Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors

Olivier Bezençon, Daniel Bur, Thomas Weller et al. · Journal of Medicinal Chemistry · 2009 · 51 citations · Full text

Medicinal Chemistry, Drug Target, Pharmaceutical Science +14

Further <i>C</i>‐Alkylations of Cyclotetrapeptides <i>via</i> Lithium and Phosphazenium (P4) Enolates: Discovery of a New Conformation

Dieter Seebàch, Olivier Bezençon, Bernhard Jaun et al. · Helvetica Chimica Acta · 1996 · 35 citations

N ‐Benzylglycine Residue, Engineering, New Conformation +15

Structure–Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and <i>in Vivo</i> Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers

Romain Siegrist, Davide Pozzi, Gaël Jacob et al. · Journal of Medicinal Chemistry · 2016 · 30 citations

Structure–activity Relationship, Pharmacotherapy, Experimental Pharmacology +17

Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers

Luboš Remeň, Olivier Bezençon, Lloyd J. Simons et al. · Journal of Medicinal Chemistry · 2016 · 23 citations · Full text

Medicinal Chemistry, Neurophysiology, Medicine +14